Piper Sandler analyst Adam Maeder maintains Inspire Medical Systems (NYSE:INSP) with a Overweight and raises the price target from $250 to $255.
Piper Sandler Maintains Overweight on Inspire Medical Systems, Raises Price Target to $255
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.